Wall Street Lunch: Not An Ecstatic Day [Seeking Alpha]
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Seeking Alpha
U.S. private sector job growth falls short of expectations, raising concerns about the labor market. Wells Fargo's Chris Harvey comes out with a new midcap portfolio of overweight-rated stocks. Listen below or on the go on Apple Podcasts and Spotify An advisory panel votes against ecstasy treatment for PTSD. (0:16) Services activity picks up. (1:34) You know what they call a Chicken Big Mac in Europe? (4:14) This is an abridged transcript of the podcast. Our top story so far. No turntables in the therapist's office just yet. Leading developers of psychedelic medicines traded lower after a panel of independent advisors to the U.S. FDA declined to endorse marketing authorization for psychiatric therapy for MDMA , also known as ecstasy. Notable decliners include Mind Medicine ( MNMD ), Atai Life Sciences ( ATAI ), COMPASS Pathways ( CMPS ), and Cybin ( CYBN The selloff comes after the FDA's Psychopharmacologic Drugs Advisory Committee voted overwhelmingly against approving
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceBusiness Wire
- MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)Business Wire
- Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know. [Yahoo! Finance]Yahoo! Finance
- Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) 18% loss last week hit both individual investors who own 46% as well as institutions [Yahoo! Finance]Yahoo! Finance
MNMD
Earnings
- 5/8/24 - Miss
MNMD
Sec Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- MNMD's page on the SEC website